American Journal of Kidney Diseases
Volume 54, Issue 4 , Pages 693-701, October 2009

Chronobiology of Arterial Hypertension in Hemodialysis Patients: Implications for Home Blood Pressure Monitoring

  • Rajiv Agarwal, MD

      Affiliations

    • Division of Nephrology, Richard L. Roudebush VA Medical Center, Indianapolis, IN
    • Richard L. Roudebush VA Medical Center, Indianapolis, IN
    • Corresponding Author InformationAddress correspondence to Rajiv Agarwal, MD, VAMC, 111N, 1481 West 10th St, Indianapolis, IN 46202
  • ,
  • Robert P. Light, BS

      Affiliations

    • Division of Nephrology, Richard L. Roudebush VA Medical Center, Indianapolis, IN

Received 28 November 2008; accepted 11 March 2009. published online 11 June 2009.

Background

Hemodialysis patients have a steady increase in blood pressure (BP) during the 44-hour interdialytic interval when ambulatory BP monitoring is used. Home BP recording allows for a longer period of monitoring between dialysis treatments and may better define the chronobiological characteristics of arterial hypertension. This study sought to determine the optimal time to perform home BP monitoring in hemodialysis patients to improve the strength of prediction of 44-hour interdialytic ambulatory BP.

Study Design

Diagnostic test study.

Setting & Participants

This is an ancillary analysis of patients participating in the Dry-weight Reduction in Hypertensive Hemodialysis Patients (DRIP) trial.

Index Test

Home BP measured 3 times daily for 1 week by using a validated oscillometric monitor on 3 occasions at 4-week intervals after randomization. Home BP measured during the first third, second third, and last third of time elapsed after the dialysis treatment, as well as each third of the dialysis treatment, was compared with the overall ambulatory BP.

Reference Tests

Interdialytic ambulatory BP measured on 3 occasions at 4-week intervals after randomization.

Results

During the interdialytic interval, we found an increase in systolic ambulatory BP of 0.30 ± 0.36 mm Hg/h and an increase in systolic home BP of 0.40 ± 0.25 mm Hg/h. This relationship in home BP reached a plateau after approximately 48 hours. A similar pattern was seen for diastolic home BP. Probing dry weight steepened the slope of ambulatory BP, but did not alter the time-dependent relationship of home BP. Home BP was on average higher (bias) by 14.1 (95% confidence interval, 12.0 to 16.2)/5.7 mm Hg (95% confidence interval, 4.6 to 6.9). The SD of differences between methods (precision) was 4.6/2.8 mm Hg. Measurement of BP during each third of the interdialytic interval gave the best precision, measured by using model fit compared with ambulatory BP measurements.

Limitations

Our cohort was overrepresented by African American hemodialysis patients. Whether African American participants have a different pattern of BP response than non–African American participants in the interdialytic period is not known.

Conclusions

Our findings suggest that time elapsed after a dialysis treatment must be considered in interpreting home BP recordings in hemodialysis patients. Home BP measured in each third of the interdialytic interval is likely to yield the most reliable BP estimate.

Index Words: Home blood pressure (BP), ambulatory blood pressure (BP) monitoring, hemodialysis, hypertension, chronobiology

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Originally published online as doi: 10.1053/j.ajkd.2009.03.018 on June 11, 2009.

 Trial registration: www.ClinicalTrials.gov; study number: NCT00067665.

PII: S0272-6386(09)00642-8

doi:10.1053/j.ajkd.2009.03.018

American Journal of Kidney Diseases
Volume 54, Issue 4 , Pages 693-701, October 2009